Chapter 4. Pharmacology Flashcards

1
Q
  1. Which of the following is true regarding seizures
    as one of the multiple side effects from the use
    of opioids?
    (A) Morphine and related opioids can cause
    seizure activity when moderate doses
    are given
    (B) Seizure activity is more likely with
    meperidine, especially in the elderly
    and with renal dysfunction
    (C) Seizure activity is mediated through
    stimulation of N-methyl-D-aspartate
    (NMDA) receptors
    (D) Naloxone is very effective in treating
    seizures produced by morphine and
    related drugs including meperidine
    (E) Seizure activity is most likely related
    with the fact that opioids stimulate the
    production of γ-aminobutyric acid
    (GABA)
A
  1. (B) Extremely high doses of morphine and
    related opioids can produce seizures, presumably
    by inhibiting the release of GABA
    (at synaptic level).
    Normeperidine a metabolite of meperidine
    is prone to produce seizures and tends to
    accumulate in patients with renal dysfunction
    and in the elderly.
    Naloxone may not effectively treat seizures
    produced by meperidine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Which of the following is true regarding respiratory
    depression related to the use of opioids?
    (A) Opioid agonists, partial agonists, and
    agonist/antagonists produce the same
    degree of respiratory depression
    (B) Opioids produce a leftward shift of the
    CO2 response curve
    (C) Depression of respiration is produced
    by a decrease in respiratory rate, with a
    constant minute volume
    (D) Naloxone partially reverses the opioidinduced
    respiratory depression
    (E) The apneic threshold is decreased
A
  1. (E) Opioids produce a dose-dependant respiratory
    depression by acting directly on the respiratory
    centers on the brainstem. Partial agonist
    and agonist-antagonist opioids are less likely to
    cause severe respiratory depression, as are the
    selective K-agonist.
    Therapeutic doses of morphine decrease
    minute ventilation by decreasing respiratory
    rate (as oppose to tidal volume).
    Opioids depress the ventilatory response
    to carbon dioxide; the carbon dioxide–response
    curve shows a decrease slope and rightward
    shift.
    The apneic threshold is decreased and also
    the increase in ventilatory response to hypoxemia
    is blunted by opioids.
    Naloxone can effectively and fully reverse
    the respiratory depression from opioids.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. The use of which of the following opioids would
    produce the greatest incidence of delayed respiratory
    depression?
    (A) 25 μg intravenous (IV) fentanyl (bolus)
    (B) 4 mg IV morphine (bolus)
    (C) 5 μg IV sufentanil (bolus)
    (D) 8 mg epidural, preservative free
    morphine
    (E) 0.05 mg intrathecal, preservative free
    morphine
A
  1. (D) Delayed respiratory depression is likely to
    occur with larger dose of epidural opioids, particularly
    morphine which is hydrophilic and
    therefore subject to spread in the cerebrospinal
    fluid (CSF), reaching the respiratory center in
    the brainstem.
    Intrathecal doses of morphine produce only
    a uniphasic pattern of respiratory depression.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
144. Opioids in general reduce the sympathetic
output and produce a dose-dependant bradycardia,
EXCEPT
(A) morphine
(B) fentanyl
(C) meperidine
(D) sufentanil
(E) alfentanil
A
  1. (C) High doses of any opioid reduce sympathetic
    output allowing the parasympathetic
    output to predominate. The heart rate decreases
    by stimulation of the vagal center, especially
    with high-doses.
    Meperidine because of its similarity to
    atropine may elevate the heart rate after IV
    administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. What is the main mechanism by which opioids
    produce analgesia?
    (A) Coupling of opioid receptors to sodium
    and potassium ion channels, therefore
    inhibiting neurotransmitter release
    (presynaptic) and inhibiting neuronal
    firing (postsynaptically)
    (B) Coupling of opioid receptor to potassium
    and calcium channels, inhibiting
    neurotransmitter release (presynaptic),
    and inhibiting neuronal firing (postsynaptically)
    (C) Coupling of opioid receptors to sodium
    and calcium channels, inhibiting
    neurotransmitter release (presynaptic),
    and inhibiting neuronal firing
    (postsynaptically)
    (D) Coupling of opioid receptors to potassium
    and calcium channels, inhibiting
    neuronal firing (presynaptically), and
    inhibiting neurotransmitter release
    (postsynaptically)
    (E) All the options are true
A
  1. (B) Opioid receptors are coupled to G proteins,
    able to affect most of the time, protein phosphorylation
    via a second messenger, thereby
    altering the conductance of potassium and calcium
    ion channels. This is believed to be the
    main mechanisms by which endogenous and
    exogenous opioids produce analgesia.
    The opening of potassium channels—the most
    well documented—will inhibit the release of neurotransmitters,
    including substance P and glutamate
    if the receptors are presynaptic. And will
    inhibit neuronal firing by hyperpolarization of the
    cell if the receptors are postsynaptic on the neurons.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Main mechanics of spinal opioid analgesia is via
    (A) activation of presynaptic opioid receptors
    (B) activation of postsynaptic opioid
    receptors
    (C) activation of opioid receptors on the
    midbrain
    (D) activation of opioid receptors on the RVM
    (E) all of the above
A
  1. (A) The different type of opioid receptors contribute
    in different proportions to the total
    opioid receptors in the spinal cord. μ-Receptors
    constitute 70%, δ-receptors 24% and κ-receptors
    6%. The main mechanism of spinal opioid analgesia
    is through presynaptic activation of opioid
    receptors.
    Opioid receptors are synthesized in small
    diameter DRG cell bodies and transported centrally
    and peripherally. They are mainly (70%)
    located presynaptically on small diameter nociceptive
    primary afferents (C and A-δ fibers).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
147. Opioids act on what type of receptors targets?
(A) μ-, δ-, κ-, And ORL receptors
(B) Voltage-dependent sodium channels
(C) α2B-Adrenoreceptors
(D) NMDA receptors
(E) All of the above
A
  1. (E) Opioids produce analgesia primarily through
    interaction with μ-receptors. The activation of κ-
    and δ-receptors also causes analgesia.The ORL receptor is a member of the opioid
    receptors, although ligands do not have the same
    high affinity for this type of receptors, but effects
    of high-affinity ligands, such as antinociception,
    proprioception/hyperalgesia, allodynia and no
    effect have been reported.
    Analysis has shown that some opioid
    actions are not mediated by opioid receptors,
    morphine can inhibit voltage-dependant sodium
    (Na) current, meperidine can block voltage-
    dependant sodium (Na) channels.
    Meperidine also has agonist activity at the
    α2B-adrenoreceptor subtype.
    Methadone, meperidine, and tramadol
    inhibit serotonin and norepinephrin reuptake.
    High concentrations of opioids, including
    morphine, fentanyl, codeine, and naloxone
    directly inhibit NMDA receptor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
148. Which of the following statements is true
regarding the use of oxycodone?
(A) Analgesic efficacy is not comparable
with that of morphine
(B) Typically has been used in combination
with nonopioids
(C) Not available as a long-acting
preparation
(D) Lower bioavailability than that of
morphine
(E) Consistently shows a higher induced
rate of hallucinations and itching when
compared with morphine
A
  1. (B) Oxycodone a semisynthetic derivative of
    thebaine and has analgesic efficacy comparable
    with that of morphine, with a median oxycodone
    to morphine dose ratio of 1 to 15.
    Oxycodone has been typically used in
    combination with nonopioids (acetaminophen,
    aspirin) and a long-acting preparation is available,
    which has popularized its use in cancer
    patients.
    It has a higher bioavailability than that of
    morphine (approximately 60%).
    There are not consistent observations on
    reduced rate of hallucinations and itching when
    compared with morphine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. One important characteristic of methadone that
    has to be considered when prescribing it on an
    outpatient basis:
    (A) Usually there is a low chance for interactions
    on patients taking multiple
    medications
    (B) Withdrawal symptoms are as severe as
    with morphine
    (C) Rarely used in opioid addiction
    (D) Sedation and respiratory depression can
    outlast the analgesic action
    (E) Allows rapid titration
A
  1. (D) Methadone unlike morphine is metabolized
    through N-demethylation by the liver
    cytochrome P-450 enzyme, which activity can
    vary widely in different people.
    Methadone should be administered with
    caution in patients receiving multiple medications,
    specially antivirals and antibiotics.
    Methadone’s withdrawal symptoms tend to
    be less severe than morphine’s, this and its long
    duration of action, good oral bioavailability, and
    high potency made it the maintenance drug or
    detoxification treatment of opioid addiction.
    Methadone has biphasic elimination. Along
    β-elimination phase (ranges from 30 to 60 hours)
    producing sedation and respiratory depression
    can outlast the analgesic action which equates
    the α-elimination phase (6-8 hours).This biphasic
    pattern explains why methadone is required
    once a day for opioid maintenance therapy and
    every 4 to 8 hours for analgesia.
    Rapid titration is not possible, making this
    drug more useful for stable type of pain.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
150. What property of methadone makes it a good
option for opioid rotation, when tolerance
develops?
(A) Serotonin agonist
(B) α2B-Adrenoreceptor agonist
(C) μ-Agonist
(D) NMDA agonist
(E) NMDA antagonist
A
  1. (E) When tolerance to opioids, usually after
    use over long periods of time, opioid rotation,
    resting period off opioids, and addition of an
    NMDA antagonist are a number of strategies
    available.
    Opioid rotation, switching from one opioid
    to another may be helpful because of partial
    cross tolerance between opioids. Because
    methadone has NMDA receptor antagonist
    properties, makes it a good choice.
    Methadone is: μ- and δ-antagonist, NMDA
    inhibitor, inhibitor of serotonin and norepinephrine
    reuptake.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
151. Which one of the following is the only opioid
with prolonged activity not achieved by
controlled-released formulation?
(A) Oxycodone
(B) Fentanyl
(C) Morphine
(D) Codeine
(E) Methadone
A
  1. (E) Methadone is the only opioid with prolonged
    activity not achieved by controlledrelease
    formulation.
    Oxycodone can be formulated as controlledrelease.
    Codeine half-life is 2 to 4 hours.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
152. Which of the following opioids is used in the
office-based treatment of addiction?
(A) Naloxone
(B) Morphine
(C) Tramadol
(D) Buprenorphine
(E) Meperidine
A
  1. (D) Buprenorphine is a semisynthetic opioid
    with partial activity at the μ-receptor and very
    little activity at the κ- and δ-receptors.
    It has high affinity but low intrinsic activity
    at the μ-receptor and has a pharmacologic
    ceiling owing to its partial agonist activity.
    It is available in the United States to be
    used in the office-based treatment of addiction.
    It can be given for withdrawal of heroin or
    methadone, or used as a maintenance of addicts.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
153. Pharmacologic properties of fentanyl that make
it an ideal drug for transdermal and transmucosal
administration is
(A) high lipid solubility, high molecular
weight, and high potency
(B) low lipid solubility, high molecular
weight, and high potency
(C) low lipid solubility, low molecular
weight, and low potency
(D) high lipid solubility, low molecular
weight, and high potency
(E) high lipid solubility, low molecular
weight, and low potency
A
  1. (D) Fentanyl is a potent mu agonist, with high
    lipid solubility, low molecular weight and high
    potency, making it an ideal drug for transdermal
    and transmucosal administration.
    92% of fentanyl delivered transdermally
    reaches the circulation as unchanged fentanyl.
    Transmucosal route at the buccal and sublingual
    mucosa skips the first pass effect and
    overall bioavailability is 50%.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. Opioids can have drug interactions with
    (A) tricyclic antidepressants (TCAs)
    (B) selective serotonin reuptake inhibitor
    (SSRIs)
    (C) monoamine oxidase inhibitors (MAOIs)
    (D) metoprolol
    (E) all of the above
A
  1. (E) Opioids can have interactions with multiple
    medications, including all the medications
    mentioned above. One of the most remarkable interactions occurs if meperidine and MAOIs are combined,
    severe respiratory depression or excitation,
    arrhythmias, delusions, hyperpyrexia,
    seizures and coma can be seen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
155. Which of the following is a long and cumbersome
research tool for substance abuse and is
very good but not very practical in the setting
of a busy pain clinic?
(A) Screening Tool for Addiction Risk
(STAR)
(B) Severity of Opiate Dependence
Questionnaire (SODQ)
(C) Screening Instrument for Substance
Abuse Potential (SISAP)
(D) Addiction Severity Index (ASI)
(E) Prescription Drug Use Questionnaire
(PDUQ)
A
  1. (D) The Addiction Severity Index (ASI) is especially
    effective for evaluating the need for
    substance-abuse treatment. It is a 200-item,
    hour-long assessment of seven potential problem
    areas designed to be administered by a
    trained interviewer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. An opioid specific five-question self-administered
    tool which can be completed in less than 5 minutes
    to help predict patients at high-risk for
    exhibiting aberrant opioid-related behavior is
    (A) Prescription Drug Use Questionnaire
    (PDUQ)
    (B) Opioid Risk Tool (ORT)
    (C) Screener and Opioid Assessment for
    Patients with Pain (SOAPP)
    (D) Screening Instrument for Substance
    Abuse Potential (SISAP)
    (E) Severity of Opiate Dependence
    Questionnaire (SODQ)
A
  1. (B) The Opioid Risk Tool (ORT) is a fivequestion
    self-administered assessment that can
    be completed in less than 5 minutes and used
    on a patient’s initial visit. Personal and family
    history of substance abuse; age; history of
    preadolescent sexual abuse; and the presence of
    depression, attention-deficit disorder (ADD),
    obsessive-compulsive disorder (OCD), bipolar
    disorder, and schizophrenia are assessed. The
    ORT accurately predicted which patients were
    at the highest and the lowest risk for exhibiting
    aberrant, drug-related behaviors associated
    with abuse or addiction.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
157. The opioid which is largely metabolized by
CYP3A4 is
(A) morphine
(B) fentanyl
(C) methadone
(D) hydromorphone
(E) oxymorphone
A
  1. (B)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  1. Which of the following is correct regarding
    patients who are prescribed and taking
    hydrocodone and found to have different opioid
    in their urine drug-testing results?
    (A) Norfentanyl, which is expected
    (B) Hydrocodeine, which is expected as a
    normal metabolite
    (C) Hydromorphone, which is expected as a
    normal metabolite
    (D) Hydromorphone, which is unexpected
    and patient is probably taking another
    opioid
    (E) Hydrocodeine, which is unexpected and
    patient is probably taking another
    opioid
A
  1. (C)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. An opioid-specific instrument which may be
    useful in predicting opioid misuse and is available
    as a 5-, 14-, or 24-item questionnaire as well
    as a revised version designed to be less susceptible
    to overt deception than the original version is
    (A) Prescription Drug Use Questionnaire
    (PDUQ)
    (B) Opioid Risk Tool (ORT)
    (C) Screener and Opioid Assessment for
    Patients with Pain (SOAPP)
    (D) Screening Instrument for Substance
    Abuse Potential (SISAP)
    (E) Severity of Opiate Dependence
    Questionnaire (SODQ)
A
  1. (C) Screener and Opioid Assessment for
    Patients with Pain (SOAPP) is a survey tool
    used to predict opioid abuse and is available as
    a 5-, 14-, 24-item questionnaire. Although the
    five-item questionnaire [SOAPP V LO-SF (5Q)]
    is less sensitive and specific than the longer
    version, it may suffice for use in primary care
    settings. The SOAPP-SF is scored by adding
    up the ratings of each of the five questions. The
    SQ SOAPP uses a cutoff score of 4 or above
    (of a possible 20) with a score of more than 4,
    indicating that the subject may have a potentially
    increased risk of opioid abuse.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
160. Aclassic example of an opioid partial agonist is
(A) naltrexone
(B) butorphanol
(C) nalbuphine
(D) buprenorphine
(E) pentazocine
A
  1. (D)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
  1. A popular mnemonic for following relevant
    domains of outcome in pain management for
    patients on long-term opioid therapy is the socalled
    4 A’s which include all the following,
    EXCEPT
    (A) analgesia
    (B) activities of daily living
    (C) adverse events
    (D) affect
    (E) aberrant drug-taking behaviors
A
  1. (D)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
162. A popular pain assessment scale which is utilized
by preverbal toddler and nonverbal children
through age 7 years who may be treated
with opioids is
(A) CRIES
(B) APPT
(C) FACES
(D) FLAC C
(E) N-PASS
A
  1. (D)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
163. The opioid which has some component of
metabolism by CYP1A2 is
(A) morphine
(B) fentanyl
(C) methadone
(D) hydromorphone
(E) oxymorphone
A
  1. (C)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
164. The opioid which is a metabolite of oxycodone
via 3-0-demethylation is
(A) hydrocodone
(B) morphine
(C) codiene
(D) hydromorphone
(E) oxymorphone
A
  1. (E)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
165. Which of the following two opioids are inherently, pharmacologically, and relatively longacting? (A) Morphine and oxycodone (B) Morphine and oxymorphone (C) Oxycodone and fentanyl (D) Methadone and levorphanol (E) Methadone and oxymorphone
165. (D)
26
166. Oral transmucosal fentanyl citrate (OTFC) is applied against the buccal mucosa. The percentage of the total dose which is absorbed from the gastrointestinal (GI) tract but escapes hepatic and intestinal first-pass elimination is (A) 25% (B) 33% (C) 50% (D) 65% (E) 75%
166. (A)
27
``` 167. OTFC is applied against the buccal mucosa. The total apparent bioavailability is (A) 25% (B) 33% (C) 50% (D) 65% (E) 75% ```
167. (C)
28
``` 168. The fentanyl buccal tablet (FBT) utilizes an effervescent drug delivery system and achieves an absolute bioavailability of (A) 25% (B) 33% (C) 50% (D) 65% (E) 75% ```
168. (D)
29
169. After intramuscular administration of fentanyl citrate, the time to onset of analgesia is roughly (A) 1 to 3 minutes (B) 7 to 15 minutes (C) 15 to 30 minutes (D) 20 to 40 minutes (E) 30 to 50 minutes
169. (B)
30
``` 170. The oral bioavailability of morphine is roughly (A) 10% to 20% (B) 25% to 35% (C) 35% to 45% (D) 40% to 55% (E) 50% to 60% ```
170. (B)
31
``` 171. In humans, methadone acts as (A) an agonist-antagonist (B) a pure μ-agonist (C) a μ-agonist but also with significant actions at the δ-opioid receptor (D) a μ-agonist but also with significant actions at the κ-receptor (E) a μ-, δ-, and κ-agonist ```
171. (B)
32
``` 172. Atool which documents a quantitative assessment of various opioid-adverse effects is the (A) Pain Assessment and Documentation Tool (PADT) (B) Translational Analgesic Score (TAS) (C) SAFE score (D) Numerical Opioid Side Effect (NOSE) (E) Severity of Opioid Dependence Questionnaire (SODQ) ```
172. (D)
33
``` 173. Which of the following is the best opioid to administer for analgesia in a patient with chronic kidney disease stage V? (A) Codeine (B) Meperidine (C) Morphine (D) Fentanyl (E) Propoxyphene ```
173. (D)
34
174. Which of the following is the most prescribed opioid in the United States, which also undergoes O-demethylation to dihydromorphine and its major metabolites excreted into the urine are dihydrocodeine and nordihydrocodeine? (A) Codeine (B) Dihydrocodeine (C) Hydrocodone (D) Hydromorphone (E) Morphine
174. (C)
35
175. Which of the following is essentially responsible for opioid-induced respiratory depression? (A) μ-Receptor (B) δ-Receptor (C) κ-Receptor (D) σ-Receptor (E) ORL 1 receptor
175. (A)
36
176. Propoxyphene napsylate has a higher maximum daily dose than propoxyphene hydrochloride because (A) propoxyphene napsylate is less potent than propoxyphene hydrochloride (B) propoxyphene napsylate is less toxic than propoxyphene hydrochloride (C) propoxyphene napsylate is cleared faster than propoxyphene hydrochloride (D) the napsylate salt tends to be absorbed more slowly than the hydrochloride (E) the napsylate salt makes propoxyphene less active
176. (D)
37
``` 177. When considering opioid rotation to methadone, which of the following is the most appropriate next step? (A) Maintain the equianalgesic dose (B) Reduce the dose by 10% to 25% (C) Reduce the dose by 25% to 50% (D) Reduce the dose by 50% to 75% (E) Reduce the dose by 75% to 90% ```
177. (E)
38
``` 178. When considering opioid rotation to fentanyl, which of the following is the most appropriate step? (A) Maintain the equianalgesic dose (B) Reduce the dose by 10% to 25% (C) Reduce the dose by 25% to 50% (D) Reduce the dose by 50% to 75% (E) Reduce the dose by 75% to 90% ```
178. (A)
39
``` 179. The equianalgesic conversion ratio of oral oxymorphone to intravenous morphine is (A) 1 to 1 (B) 1 to 2 (C) 1 to 3 (D) 1 to 4 (E) 1 to 5 ```
179. (A)
40
180. By approximately what percentage is codeine ineffective as an analgesic in the Caucasian population owing to genetic polymorphisms in CYP2D6 (the enzyme necessary to Omethylate codeine to morphine)? (A) 2% (B) 5% (C) 10% (D) 25% (E) 33%
180. (C)
41
181. Which of the following is the correct statement regarding the pharmacologic properties of NSAIDs? (A) They readily cross the blood–brain barrier (B) Their chemical structure consists of aromatic rings connected to basic functional groups (C) They act mainly in the periphery (D) They have a high renal clearance (E) They are not metabolized by the liver
181. (C) The NSAIDs are weak organic acids, consisting in one or two aromatic rings connected to an acidic functional group. They do not cross the blood–brain barrier, are 95% to 99% bound to albumin, are extensively metabolized by the liver and have low renal clearance (
42
182. What are the advantages of COX-2 inhibitors versus NSAIDs? (A) Protective renal effects (B) Less GI side effects (C) Protective cardiovascular effects (D) Inhibits production of thromboxane A2 (E) Increases production of lipooxygenase
182. (B) Coxibs do not have any advantages in terms of renal effects. COX-2 inhibitors are associated with less GI toxicity than standard NSAIDs but they are more expensive. There is a possible increased risk of myocardial infarction (MI) and thrombotic stroke events associated with the continuosly long-term use of coxibs. Those concerns led to rofecoxib and valdecoxib being withdrawn from the market in the year 2004 and 2005, respectively. Regular NSAIDs inhibit the synthesis of TXA2 by inhibiting COX-1, which is spared with the use of COX-2 inhibitors.
43
``` 183. Which of the following best fits the pharmacologic mechanisms of action of “traditional” NSAIDs? (A) Inhibition of phospholipase A2 (B) Inhibition of COX-2 (C) Inhibition of lipoxygenase (D) Inhibition of arachidonic acid (E) Inhibition of prostaglandin G/H synthase enzymes ```
183. (E) NSAIDs inhibits the prostaglandin G/H synthase enzymes, colloquially known as the COX, therefore inhibiting the synthesis of prostaglandin E, prostacyclin, and thromboxane. NSAIDs inhibit the production of not only COX-2 but also COX-1. Steroids inhibit phospholipase A2.
44
184. The main role of prostaglandins in pain is (A) as important primary pain mediators (B) sensitization of central nociceptors (C) sensitization of peripheral nociceptors (D) facilitation of the production of pain mediators (ie, bradykinin, somatostatin, histamine) (E) stimulation of κ-receptors on the spinal cord
184. (C) Prostaglandins are not important primary pain mediators, they do cause hyperalgesia by sensitizing peripheral nociceptors (to mechanical an chemical stimulation) to the effects of pain mediators, such as bradykinin, somatostatin, and histamine, producing hyperalgesia. They do so by lowering the threshold of the polymodal nociceptors of C fibers. NSAIDs act mainly in the periphery, but they may have a central effect. COX-2 induction within the spinal cord may play an important role in central sensitization. The acute antihyperalgesic action of NSAIDs has been shown to be mediated by the inhibition of constitutive spinal COX-2, which has been found to be upregulated in response to inflammation and other stressors.
45
``` 185. The effects of NSAIDs on the kidneys function or renal function may include (A) increase in renal blood flow (B) promotion of salt and water excretion (C) chronic interstitial nephritis (D) increased glomerular filtration rate (GFR) (E) chronic papillary necrosis ```
185. (C) In the kidney, prostaglandins help to maintain GFR and blood flow. They also contribute to the modulation of renin release, excretion of water, and tubular ion transport. In patients with normal renal function NSAID-induced renal dysfunction is extremely rare. Risk factors for NSAID-induced renal dysfunction are: • Prolonged and excessive NSAID use • Older patients • Chronic renal dysfunction • Congestive heart failure • Ascites • Hypovolemia • Treatment with nephrotoxic drugs (aminoglycosides and vancomycin) In these scenarios NSAIDs may decrease rapidly the GFR, release of renin, which can progress to renal failure. Sodium, water retention, hyperkalemia, hypertension, acute papillary necrosis, chronic interstitial nephritis, and nephrotic syndrome can also occur. Coxibs (COX-2 inhibitors) have similar renal effects and it should be closely monitored, as is required for conventional NSAIDs.
46
186. Platelet dysfunction secondary to the use of NSAIDs is a known effect, in long-term treatment with standard NSAIDs. What laboratory value is most compatible with these effects? (A) Prolonged prothrombin time (PT) (B) Prolonged partial thromboplastin time (PTT) (C) Prolonged activated clotting time (ACT) (D) Severely prolonged bleeding time (E) Below the upper limits of normal to mildly prolonged bleeding time
186. (E) Platelets are very susceptible to COX inhibition, which also inhibits the endogenous procoagulant thromboxane. Long-term use of standard NSAIDs produces a consistently prolonged bleeding time, but the prolongation is mild and values tend to remain below the upper limits of normal.
47
187. The duration of aspirin effect is related to the turnover rate of COX in different target tissues, because aspirin (A) competitively inhibits the active sites of COX enzymes (B) nonirreversibly inhibits COX activity (C) irreversibly inhibits COX activity (D) noncompetitively inhibits the active sites of COX enzymes (E) acetylates COX-1
187. (C) Aspirin covalently acetylates COX-1 and COX-2, irreversibly inhibiting COX activity. This makes the duration of aspirin’s effects related to the turnover rate of COX in different target tissues. NSAIDs competitively inhibit the active site of COX enzymes which relates its duration more directly to the time course of drug disposition.
48
188. The unique sensitivity of platelets to inhibition by low doses of aspirin (as low as 30 mg/d) is related to (A) first pass of aspirin through the liver (B) presystemic inhibition of platelets in the portal circulation (C) irreversible inhibition of COX (D) constitutively expression of COX-1 in platelets (E) good oral absorption
188. (B) The unique sensitivity of platelets to inhibition by low doses of aspirin, as low as 30 mg/d is related to their presystemic inhibition in the portal circulation before aspirin is deacetylated to salicylate on first pass through the liver. Aspirin irreversibly inhibits COX activity, making the aspirin’s effect related to the turnover rate of COX in different target tissues. Enzyme turnover is most notable in platelets because they are anucleated with a marked limited capacity for protein synthesis. Therefore the inhibition of platelet COX-1 (COX-2 is expressed only in megakaryocytes) last for the lifetime of the platelet, 8 to 12 days (10 days average) after therapy has been stopped. In general NSAIDs are well absorbed orally, but that is not the reason for high platelet sensitivity to ASA.
49
``` 189. How long before surgery NSAIDs are advised to be stopped? (A) 12 hours (B) 2 to 3 days (C) 7 days (D) 10 days (E) 14 days ```
189. (B) The antiplatelet effect of NSAIDs is rapidly reversible, 24 hours cessation is probably sufficient, although 2 to 3 days cessation is advised. Aspirin because of its irreversible antiplatelet effect should be stopped 10 days before elective surgery.
50
``` 190. Which of the following NSAIDs is as effective as morphine? (A) Ketoprofen (B) Indomethacin (C) Ibuprofen (D) Ketorolac (E) Diclofenac ```
190. (D) Ketorolac is one of the few NSAIDs that the FDA approved for parenteral use. It is highly efficacious, with efficacy close to that of morphine and other opioids for simple outpatient procedures to major operations. Ketorolac’s side effects, like other NSAIDs include GI bleeding, other bleeding problems, and reversible renal dysfunction (Possibly related with use of high doses or failure to recognize its contraindications). Nonunion, deleterious effects in bone osteogenesis during bone repair are some other side effects, more likely to occur if ketorolac was administered after surgery, compared with no use of NSAIDs. Decreased posterior spine fusion rates have been demonstrated in rat models, with the long-term use of indomethacin, but even the short-term administration of NSAIDs may possibly significantly affect spinal fusion. These findings have not been confirmed in humans, but many surgeons prefer to avoid the use of NSAIDs in the postoperative period of bone fusion, especially in the spine. COX-2 inhibitors can have similar effects, which is unlikely with short-term perioperative use in humans. No human studies to date document that coxibs have these negative effects in bone healing.
51
``` 191. Rare side effect of NSAIDs is (A) GI side effects (B) platelet dysfunction (C) potentially fatal hepatic necrosis (D) renal dysfunction/failure (E) all of the above ```
191. (C) All are well-known and not uncommon side effects of NSAIDs. Borderline increases of one or more liver tests, may occur in up to 15% of patients taking NSAIDs, approximately 1% of patients taking NSAIDs have shown notable increases in alanine aminotransferase (ALT) or aspartate aminotransferase (AST) (X3 or more the upper limit of normal). These findings may progress, remain unchanged, or be transient with continuing therapy. Rare cases of severe hepatic reactions, including jaundice and fatal fulminant hepatitis, liver necrosis, and hepatic failure (some with fatal outcome), have been reported with NSAIDs.
52
``` 192. Which of the following is (are) true regarding oxcarbazepine? (A) It has more adverse effects than carbamazepine (B) It is a sodium channel blocker (C) Oxcarbazepine’s dose adjustment is unnecessary for renal insufficiency (D) Its most frequent adverse effects is weight loss and dizziness (E) none of the above ```
192. (B) Oxcarbazepine [10, 11-dihydro-10-oxo-5Hdebenz (b, f) azepine-5-carboxanide] is an analogue of carbamazepine with a keto group at the 10 carbon position. It is roughly 50% protein bound in the plasma. The dose should be at least cut by half if the patient has significant renal insufficiency. The most frequent adverse effects experienced include dizziness and vertigo, weight gain and edema, GI symptoms, fatigue, and allergic-type reactions. Cross-allergy to carbamazepine occurs in about 25% of patients and may be severe.
53
``` 193. Which of the following is a typical adverse effect of pregabalin? (A) Constipation (B) Dizziness (C) Blurred vision (D) Dry mouth (E) All of the above ```
193. (E)
54
194. Which of the following is (are) false regarding gabapentin? (A) It is a first-line drug for the treatment of PHN and PDN (painful diabetic neuropathy) (B) Its dose should be reduced in renal insufficiency (C) It blocks NMDA receptors (D) It is thought to inhibit voltagedependent calcium channels (E) It has a chemical structure similar to that of GABA
194. (C) A structural analogue of GABA is considered by many practitioners to be a first-line drug for treatment of PHN and PDN because of its tolerability and efficacy. Dose should be reduced in renal dysfunction. Dose increases are usually made every 3 to 4 days.
55
195. Which of the following is true about zonisamide? (A) It is a sulfonamide drug (B) It is a sodium channel blocker (C) It is 40% to 50% protein bound (D) It may potentially lead to renal calculi (E) All of the above
195. (E)
56
196. Which of the following is true about antiepileptic drugs (AED)? (A) AEDs have analgesic effect in all subjects with neuropathic pain (B) If one AED is ineffective, it is not necessary to try another one (C) Newer AEDs have more side effects than older ones (D) AEDs could be combined with antidepressants to treat neuropathic pain (E) All of the above
196. (D)
57
``` 197. The antidepressant with the least anticholinergic and least sedating effect is (A) trazodone (B) desipramine (C) imipramine (D) doxepin (E) amitriptyline ```
197. (B) Anticholinergic side effects are generally | very significant for TCAs.
58
198. Which of the following antidepressant agent selectively inhibits serotonin reuptake with minimal effect on norepinephrine reuptake? (A) Duloxetine (B) Protriptyline (C) Paroxetine (D) Amoxapine (E) Desipramine
198. (C) Antidepressants which selectively inhibit serotonin with minimal effects on norepinephrine reuptake are referred to as SSRIs (eg, paroxetine). Protriptyline, desipramine, and amoxapine are secondary amine TCAs. Duloxetine inhibits both norepinephrine and serotonin (SNRIs).
59
``` 199. The most common adverse effects associated with TCA are (is) (A) anticholinergic effects (B) seizures (C) arrhythmias (D) hepatotoxicity (E) nephrotoxicity ```
199. (A) Side effects of antidepressants include anticholinergic effects, antihistaminergic effects, α1- aderenergic receptor bloackade, and cardiac effects. Individual may possess significant side effects in one specific area (eg, doxepin is a strong antihistaminergic agent). As a generalization,the most common adverse effects associated with TCAs are anticholinergic in nature.
60
``` 200. The least common adverse effects associated with TCA are (is) (A) dry mouth (B) seizure (C) urinary retention (D) blurred vision (E) aconstipation ```
200. (B)
61
``` 201. Compared to TCAs, SSRIs (A) are more effective in the treatment of pain (B) have more side effects (C) have less side effects (D) have more serious consequence of overdosage (E) none of the above ```
201. (C)
62
``` 202. Which of the following is false regarding tramadol? (A) It has opioid characteristics (B) There is a dose limit of 400 mg/d (C) It is a centrally acting analgesic (D) No effect on norepinepherine or serotonin (E) Inhibits the reuptake of norepinephrine and serotonin ```
202. (D) Tramadol hydrochloride is a centrally acting analgesic which is thought to provide analgesia via at least two mechanisms: some analgesia may be derived from the relatively weak interaction of tramadol with the μ-opioid receptor. The second and major mechanism, which is thought to account for at least 70% of tramadol’ s analgesic activity, is via inhibiting the reuptake of norepinephrine and serotonin
63
``` 203. The benzodiazepine which is used to treat various neuropathic pain syndromes is (A) diazepam (B) midazolam (C) clonazepam (D) flunazepam (E) lorazepam ```
203. (C) Clonazepam is a benzodiazepine—which binds to the GABAB receptor (other benzodiazepines bind to the GABAA receptor) and has been utilized to treat various neuropathic pain syndrome and lower extremity muscle conditions.
64
204. Which of the following about carisoprodol is true? (A) Naloxone may be a useful antidote to its toxicity (B) Flumazenil may be a useful antidote to its toxicity (C) It is safe to use as a long-term treatment of musculoskeletal disorders (D) It is a GABAB receptor agonist (E) It has no abuse potentia
204. (B) Carisoprodol may be useful for the short-term treatment of acute musculoskeletal disorders, especially in combination with acetaminophen, aspirin, or NSAIDs. Carisoprodol is primarily metabolized in the liver to several metabolites, including meprobamate. This metabolic conversion, although relatively small, has been postulated to be the reason that carisoprodol may have abuse potential. The formation of meprobamate from carisoprodol is by N-dealkylation via CYP2C19. Poor metabolizers of mephenytoin have a diminished ability to metabolize carisoprodol and therefore may be at increased risk of developing concentration-dependent side effects (eg, drowsiness, hypotension, CNS depression) at “usual” adult doses. Although the precise mechanisms of action of carisoprodol (as well as meprobamate) are uncertain, one theory is that they act as indirect agonists at the GABAA receptor, yielding CNS chloride ion channel conduction effects similar to benzodiazepines. Therefore, flumazenil may be a potentially useful antidote to carisoprodol toxicity.
65
205. Which of the following is true regarding tizanidine? (A) It is structurally related to clonipine (B) It is GABAB receptor agonist (C) It is GABAA receptor agonist (D) Its excretion occurs primarily through the liver (E) It is α2 agonist
205. (E) Tizanidine is an imidazoline derivative that is structurally related to clonidine. Its action is primarily derived from agonism at the α2- adrenoreceptor. Metabolism of tizanidine occurs primarily in the liver through oxidative processes, and metabolites of the parent compound have no known pharmacologic activity. Excretion of tizanidine and its metabolites occurs primarily via the kidneys (53%-66%).
66
206. Which of the following is a false statement about ziconotide? (A) It is derived from conus sea snail venom (B) It is the synthetic form of cone snail peptide (conotoxin) (C) It is effective when given intravenously or orally (D) It is N-type calcium channel blocker (E) Its common side effects are dizziness, confusion, and headache
206. (C)
67
207. Which of the following is true regarding capsaicin? (A) It is a member of the vanilloid family which binds to the TRPV1 receptor (B) It is commercially available in 0.025% and 0.075% concentrations (C) It is the active component of chili peppers (D) It depletes presynaptic substance P (E) All of the above
207. (E)
68
``` 208. The following are some of the side effects of lidocaine 5% patches, EXCEPT (A) methemoglobin (B) edema (C) erythema (D) abnormal sensation (E) exfoliation ```
208. (A)
69
``` 209. Calcitonin may be used as an adjuvant drug for all the following, EXCEPT (A) phantom limb pain (B) sympathetically maintained pain (C) cancer bone pain (D) postoperative pain (E) osteoporosis pain ```
209. (D)
70
210. Regarding the effects produced by the different subtypes of opioid receptors, which of the following is (are) true? (1) κ-Receptors produce more respiratory depression than μ-receptors (2) Opioid receptors mostly affect phosphorylation through G protein coupling (3) The stimulation of μ2-receptors to produce analgesia without respiratory depression, has been supported by several studies (4) Opioid receptors act both presynaptically and postsynaptically
210. (C) The previously proposed classification of μ- receptors into μ1 and μ2 subtypes, with the rationale that selective μ1-agonist could produce analgesia without the undesirable effects of respiratory depression has not been proven. Gene experiments have demonstrated that μ- receptors mediate all morphine activities including analgesia, tolerance, dependence, and respiratory depression. Opioid receptors are coupled to G proteins and they act mostly through phosphorylations via a second messenger. Opioids act pre- and postsynaptically. Presynaptically, inhibit the release of neurotransmitters including substance P and glutamate. Postsynaptically inhibit neurons by hyperpolarization, through the opening of potassium channels
71
211. The use of pure opioid agonists are preferred in chronic pain patients because of their (1) low association with addiction (2) superior analgesic efficacy (3) low potential for nausea and vomiting (4) easier titratable nature
211. (C) When choosing between partial agonists (ie, buprenorphine) and mixed agonist-antagonists (ie, pentazocine, nalorphine) versus pure agonists, pure opioid agonists are preferred, especially in chronic pain patients, because of their superior efficacy and easier titratable nature
72
``` 212. The systemic administration of opioids exerts its analgesic effects at what level(s)? (1) Brain cortex (2) Brainstem and medulla (3) Dorsal horn of the spinal cord (4) Sensory neuron (peripheral nervous system) ```
212. (E) Analgesic effects of systemic administration of opioids result from receptor opioid activity at different sites, including: 1. The sensory neuron in the peripheral nervous system. 2. The dorsal horn of the spinal cord (inhibition of transmission of nociceptive information). 3. The brainstem medulla (potentiates descending inhibitory pathways that modulate ascending pain signals). 4. The cortex of the brain (decreases the perception and emotional response to pain).
73
213. Which of the following condition(s) increase the likelihood of opioid-related toxicity? (1) Pregnancy (2) Renal disease (3) Cardiac heart failure (4) Cirrhotic liver disease
213. (C) The liver metabolizes opioids by dealkylation, glucuronidation, hydrolysis, and oxidation, any hepatic disease can increase the accumulation of toxic metabolites, that is, morphine-6-glucuronide, normeperidine (CNS toxicity), norpropoxyphene (cardiac toxicity). Kidneys account for 90% of opioid excretion. Therefore any hepatic or renal disease increases the likelihood of opioid-related toxicity.
74
214. Which of the following is (are) true concerning the use of epidural morphine? (1) A biphasic respiratory depression pattern can develop, with the initial phase within 30 minutes of the bolus dose and a second phase 2 to 4 hours later (2) Initial phase within 2 hours of the bolus dose and a second phase 6 to 12 hours later (3) Patients should be closely monitored for 48 hours after the administration of epidural morphine (4) Patients should be closely monitored for 24 hours after the administration of epidural morphine
214. (C) The use of hydrophilic opioids like morphine in the epidural space produces a biphasic respiratory depression pattern. One portion of the initial bolus is absorbed systemically, accounting for the initial phase, which usually occurs within 2 hours of the bolus dose. The second phase occurs 6 to 12 hours later owing to the slow rostral spread of the remaining drug as it reaches the brainstem.
75
215. Opioids should be used with caution in which of the following scenarios? (1) Emphysema (2) Kyphoscoliosis (3) Chronic obstructive pulmonary disease (COPD) (4) Obstructive sleep apnea
215. (E) Opioids should be used with caution in any situation with decrease respiratory reserve, that is, emphysema, obesity, scoliosis. Opioids that release histamine (ie, morphine) may precipitate bronchospasm, especially in asthma.
76
216. Indicate what part differs largely among the μ-, δ-, κ-, and ORL (opioid-receptor-like) receptors? (1) Transmembrane domains (2) Extracellular loops (3) Intracellular loops (4) N or C terminal tails
216. (C) The opioid receptors, μ-, δ-, κ-, ORL receptors are highly similar, their genes have been cloned in many species, including humans. The molecular structure of these G protein–coupled receptors (GPCRs) comprises 7 hydrophobic transmembrane domains interconnected by short loops, an intracellular C-terminal tail and an extracellular N-terminal domain. The transmembrane domains and intracellular loops have amino acid sequences that are 65% identical or similar, whereas the amino (N), carboxy (HOOC) terminal and the extracellular loops are very different
77
217. Opioids modify and relieve the perception of pain without detriment of other sensory mode types. While the pain is still present there is a dissociation of the emotional and sensory aspects of pain, making the patients feel more comfortable. Select the best reason(s) from the following: (1) Action of opioids on supraspinal structures, brainstem [ie, PAG (periaqueductal gray) the RVM (rostroventral medulla)], and midbrain (2) Action of opioids on peripheral structures via presynaptic receptors (3) Enhanced inhibitory activity on descending controls terminating in the dorsal horn of the spinal cord (4) Pronounced reduction in activity of OFF cells and decreased activity of ON cells
217. (B) When noxious stimuli are produced, they are transmitted to higher centers through spinal routes arriving at the parabrachial area, central gray, and the amygdala. The pathways which project to these supraspinal sites and the sites themselves contribute mostly to the emotional aspects of pain, whereas those which project to the thalamus and somatosensory cortex produce the sensory aspects of pain. Opioids suppress both pathways but the dissociation of the emotional and sensory aspects of pain is most likely produced by brain mechanisms. Opioids can also prevent the supraspinal activation by noxious stimuli through increased activity in inhibitory descending controls terminating in the dorsal horn of the spinal cord. The action of opioids on peripheral structures does not abolish the emotional aspects of pain. There is a hypothesis describing two major populations of RVM output neurons, ON cells and OFF cells. ON cells activity coincides with spinal reflexes and OFF cell activity is associated with the suppression of those reflexes. Morphine produces a pronounced reduction in the activity of ON cells.
78
218. Opioids exert their analgesic effects through (1) their central action within the central nervous system (CNS), inhibiting directly the ascending transmission of painful stimuli from the dorsal horn at the spinal cord (2) their central action within the CNS activating pain control circuits descending from the midbrain via the RVM to the spinal cord dorsal horn (3) their peripheral actions on opioid receptors and the release of endogenous opioid-like substances (4) their action on the spinal cord at a presynaptic level only
218. (A) Opioids exert their analgesic effects through central and peripheral mechanisms. Although it was believed that opioids act exclusively within the CNS, there are opioid receptors outside the CNS able to produce analgesic effects in the periphery. The opioid receptors are synthesized in the dorsal root ganglia (DRG) and transported toward the peripheral sensory nerve endings. These peripheral actions are enhanced under inflammatory conditions. Immune cells may release endogenous opioid-like substances, which act on opioid receptors located on the primary sensory neuron. Centrally, the opioids inhibit directly the ascending transmission of painful stimuli arising from the spinal cord (dorsal horn) and activate circuits that descend from the midbrain via the RVM to the dorsal horn.
79
219. Which of the following is (are) true regarding pharmacologic characteristics of opioids? (1) Opioids are the primary pain medication with ceiling effects (2) Opioids are the primary pain medication with no ceiling effects (3) There are sex related differences in opioid-mediated responsiveness (4) There are no sex related differences in opioid-mediated responsiveness
219. (C) Opioids are a primary pain medication that has no ceiling effect , and there is no “mild” opioids, because they can be titrated to produce equianalgesic effects. Although some opioids have been considered “mild” because of dose-related side effects or because commercial preparations are combined with adjuvant drugs (ie, aspirin or acetaminophen) limiting its dosing. There is evidence indicating that morphine has greater potency but slower speed of onset and offset in women. Opioids acting in μ- and κ-receptors constrict the pupil by exciting the Edinger Westphal nucleus (parasympathetic). Long-term opioid use can produce tolerance to miotic effects of opioids.
80
220. Tramadol has some different characteristics when compared to some other opioids including (1) same side effects as morphine (2) risk of respiratory depression is lower at equianalgesic doses from that produce with conventional opioids (3) less incidence of nausea and vomiting (4) low abuse potential
220. (C) Tramadol has a different profile from that of conventional opioids. It is very effective in the treatment of severe pain, with fewer side effects than morphine. The risk of respiratory depression is lower at equianalgesic doses; the risk of fatal respiratory depression is minimal at appropriate oral dosing, and limited essentially to patients with severe renal failure. Tramadol has a low abuse potential, however, nausea and vomiting occur at the same rate as with other opioids.
81
``` 221. Morphine should be used with caution in which situations/conditions? (1) Short bowel syndrome (2) Mild liver dysfunction (3) Vomiting or severe diarrhea (4) Renal dysfunction ```
221. (D) Morphine is metabolized by the liver to morphine-6-glucuronide which is more potent than morphine itself and has a longer half-life, resulting in additional analgesia. Morphine is also metabolized to morphine-3-glucuronide which causes adverse effects and is inactive according to others. Renal dysfunction can produce accumulation of morphine-6-glucuronide, with subsequent opioid effects, including respiratory depression, so morphine should be used with care in renal dysfunction. Patients with liver failure can tolerate morphine (even in hepatic precoma), because glucuronidation is rarely impaired. Short bowel syndrome and vomiting and diarrhea limit the efficacy of controlled-release morphine, which relies in slow absorption from the GI tract
82
222. The transdermal fentanyl patch has differences versus sustained-release morphine in patients with cancer and chronic pain: (1) It can be used when the oral route can not be used (2) It is 80 times as potent as morphine (3) It causes less constipation than sustained-release morphine (4) Peak plasma concentration occurs in 6 to 12 hours
222. (A) Fentanyl is 80 times as potent as morphine. Transdermal fentanyl is extremely useful as a treatment in chronic pain especially in cancer patients. It causes less constipation than sustained-release morphine. Ninety-two percent of fentanyl delivered transdermally reaches systemic circulation as unchanged fentanyl. Peak plasma concentration after application is 12 to 24 hours and a residual depot remains in subcutaneous tissues for about 24 hours after removal of the patch, therefore care needs to be taken with the use of transdermal system.
83
223. Which of the following is (are) correct regarding the use of meperidine? (1) The use of meperidine should be limited to 1 to 2 days in the management of acute pain (2) Normeperidine is a neurotoxic metabolite of meperidine (3) Meperidine should be avoided in the management of chronic pain (4) The use of meperidine is recommended in elderly patients
223. (A) Normeperidine is a neurotoxic metabolite of meperidine; its accumulation is more likely in patients with poor renal function, especially in the elderly. The use of meperidine should be limited to 1 to 2 days for acute pain and should be avoided in chronic pain management.
84
224. Which of the following is (are) true regarding opioids distribution and biotransformation (metabolism)? (1) Fentanyl is highly protein bound (2) Fentanyl distributes to fat tissue and redistributes from there into the systemic circulation (3) Opioids are metabolized by the liver, CNS, kidney, lungs, and placenta (4) Opioid distribution is independent of protein binding and lipophilicity
224. (A) Opioid distribution is a function of lipophilicity and plasma protein binding. Fentanyl is both lipophilic and highly protein bound. Fentanyl also distributes to fat tissue and redistributes slowly from there into the systemic circulation. The opioids are mainly metabolized in the liver and to a minor extent in CNS, kidneys, lung, and placenta.
85
225. What is (are) the neuroendocrine effects produced by opioids? (1) Hypogonadism (2) Hypothyroidism (3) Decreased cortisol levels (4) Decreased pituitary release of prolactin
225. (B) Investigations have showed that endogenous and exogenous opioids can bind to opioid receptors primarily in the hypothalamus but also in the pituitary gland and testes, decreasing the release of gonadotropin-releasing hormone (GnRH), luteinizing hormone–follicle-stimulating hormone (LH–FSH), and testosterone-testicular interstitial fluid, respectively. Clinically this will manifest as hypogonadism, including: loss of libido, impotence, infertility (males and females), depression, anxiety, loss of muscle strength, fatigue, amenorrhea, irregular menses, galactorrhea, osteoporosis, and fractures. Opioids have also been found to decrease cortisol levels and cortisol responses, but they do not modify thyroid function. Opioids also have been shown to increase pituitary release of prolactin in preclinical studies and one study also documented decreased growth hormone (GH), without clear clinical significance.
86
``` 226. Which of the following drugs may show interactions with NSAIDs/COX-2 inhibitors? (1) Angiotensin-converting enzyme (ACE) inhibitors (2) Furosemide (3) Warfarin (4) Lithium ```
226. (E) NSAIDs may diminish the antihyperptensive effects of ACE inhibitors (ACEIs) and the natriuretic effect of furosemide and thiazides in some patients. Anticoagulant therapy with warfarin should be monitored, especially in the first few days of changing therapy, because all the currently available COX-2 inhibitors may increase serum warfarin levels. Lithium levels may also increase with celecoxib, valdecoxib, and rofecoxib.
87
``` 227. Which of the following is (are) contraindicated in patients allergic to sulfonamides? (1) Rofecoxib (2) Valdecoxib (3) Meloxicam (4) Celecoxib ```
227. (C) All sulfonamides can be regarded to one of the two main biochemical categories, arylamines or nonarylamines. The sulfonamide allergicity is thought to be related to the formation of hydroxylamine a metabolite of the nonarylamine group. Celecoxib and valdecoxib belong to the former group and are contraindicated in patients allergic to sulfonamides.
88
228. Anti-inflammatory agent(s) which may possess advantages when GI side effects are a concern include (1) ibuprofen (2) nabumetone (3) diclofenac (4) coxibs
228. (C) Nabumetone (nonacidic prodrug metabolized to a structural analogue of naproxen) is minimally toxic to the GI tract, and it is the choice when GI side effects are a special concern. Coxibs are also a good choice if there is any history of GI symptoms. Coxibs are associated with less GI toxicity than standard NSAIDs, since they do not inhibit the constitutive COX-1 and therefore the production of the cytoprotective PGI2 in the stomach mucosa.
89
229. Which of the following is (are) true for coxibs versus NSAIDs? (1) Coxibs are associated with less GI side effects (2) Coxibs have similar renal effects (3) Coxibs are not associated with platelet dysfunction (4) Coxibs are associated with increased incidence of nonunion and delayed bone healing
229. (A) Coxibs show less GI side effects, and have similar renal effects to those of standard NSAIDs. COX-2 is not present in platetelets, and up-to-date under most conditions, coxibs are not associated with platelet dysfunction. There is no documentation in humans that the coxibs impairs bone remodeling and delay fracture healing.
90
230. Which of the following NSAIDs have higher potency (either analgesic or anti-inflammatory or both) compared to ASA? (1) Diflunisal (2) Indomethacin (3) Ketorolac (4) Diclofenac
230. (E) The potency of NSAIDs in general is similar or equipotent to ASA, except for diflunisal, indomethacin, ketorolac, and diclofenac. Diflunisal is a difluorophenyl derivative of salicylic acid, more potent than aspirin in anti-inflammatory tests in animals. It is used primarily as analgesic in osteoarthritis and musculoskeletal sprains, where is 3 to 4 times more potent than ASA. It also produces fewer and less intense GI and antiplatelet effects than ASA. Indomethacin is 10 to 40 times more potent inhibitor of COX than ASA, but intolerance limits its dosing to short-term. It also may have a direct, COX-independent vasoconstrictor effect. Some studies have suggested the possibility of increased risk of MI and stroke, but controlled trials have not been performed. Ketorolac is a potent analgesic, poor antiinflammatory. Has been used as a short term alternative (less than 5 days) to opioids, for moderate to severe pain. Diclofenac is more potent than ASA; its potency against COX-2 is substantially greater than that of indomethacin, naproxen, or several other NSAIDs. Naproxen is more potent in vitro.
91
``` 231. Scenarios in which the adjunct use of NSAIDs can be beneficial in postoperative pain: (1) Use of opioids (2) No history of induced-opioid side effects (3) Preexisting ventilatory compromise (4) History of GI bleeding ```
231. (B) Amultimodal approach (the combination of different, appropriate pain treatments) seems to be the best approach in terms of synergy and reducing the side effects of each. The opioid sparing effects of NSAIDs use in postoperative pain, has been confirmed in multiple controlled trials. This can be of particular benefit when the opioids side effects are especially undesirable, including preexisting ventilatory compromise, strong history of opioid induced side effects and the very young
92
``` 232. Options that can be offered to patients with increased risk of GI toxicity: (1) Diclofenac with enteric coat (2) NSAIDs combined with GI prophylaxis (3) NSAIDs combined with antacids (4) Coxibs ```
232. (C) Coxibs are a good choice in patients with a history of GI symptoms or sensitivity to NSAIDs, because they are associated with less GI side effects than standard NSAIDs. Although they are more expensive and they carry the concern of increase cardiovascular risk (increased thrombotic events: MI, stroke), with continuous and prolonged used. Standard NSAIDs combined with GI prophylaxis seems to be equally effective in terms of efficacy and freedom from GI toxicity. The GI prophylaxis can consist of: parietal cell inhibitors (acid inhibitors, ie, omeprazole), prostaglandin analogues (misoprostol), and H blockers (ie, ranitidine, cimetidine). Diclofenac is available in combination with misoprostol, retaining the efficacy of diclofenac while reducing the frequency of GI toxicity; it is cost effective relative to coxibs despite the cost of added misoprostol. Diclofenac with enteric coat does not offer a marked less GI toxicity.
93
``` 233. Which of the following is (are) NSAID’s role in cancer? (1) Synergistic effect of NSAIDs and opioids (2) Bone and soft tissue pain relief (3) Ability to reduce the side effects of opioids (4) Visceral pain relief ```
233. (E) The combination of opioid/nonopioid (ie, NSAIDs) for mild to moderate cancer pain is synergistic and has the ability to reduce the side effects of each drug. NSAIDs in advanced cancer, are particularly useful for bone pain (distension of the periosteum by metastases, for soft tissue pain (distension or compression of tissues), and for visceral pain (irritation of the pleura or peritoneum). ASA and other salicylates are contraindicated in children and young adults (younger than 20 years) with fever associated with viral illness, owing to the association with Reye syndrome. Acetaminophen: nonacidic, crosses the blood–brain barrier, acts mainly in the CNS, peripheral, and anti inflammatory effects are weak
94
234. Anti-inflammatory agent(s) which do not interfere with the cardioprotective effects of “lowdose” aspirin include (1) naproxen (2) ibuprofen (3) ketorolac (4) celecoxib
234. (D) Unlike ibuprofen, naproxen, and ketorolac, celecoxib does not interfere with the inhibition of platelet COX-1 activity and function by aspirin.
95
235. Which of the following is (are) true regarding carbamazepine? (1) It blocks voltage-dependent sodium channels (2) Bicuculline antagonizes its antinociceptive effect (3) It was first used for trigeminal neuralgia (4) All of the above
235. (E)
96
``` 236. Pregabalin is Food and Drug Administration (FDA) approved for (1) diabetic neuropathy (2) postherpetic neuralgia (PHN) (3) fibromyalgia (4) none of the above ```
236. (A) The drug was approved by the European Union in 2004. Pregabalin received US FDA approval for use in treating epilepsy, diabetic neuropathy pain, and pain in June 2005, and appeared on the US market in 2005. In June 2007 the FDA approved it as a treatment for fibromyalgia. It was the first drug to be approved for this indication and remained the only one, until duloxetine gained FDA approval for the treatment of fibromyalgia in 2008.
97
237. Which of the following is (are) true regarding gabapentin? (1) It has chemical a structure similar to GABA (2) It acts directly at GABA-binding site in the CNS (3) It inhibits voltage-dependent calcium channels (4) It is the drug of choice for fibromyalgia
237. (B) GBP has a chemical structure similar to GABA. It seems not to act directly at the GABAbinding site in the CNS, however. The mechanism of action is still unclear. It may enhance the release or activity of GABA and seems to inhibit voltage-dependent sodium channels
98
238. Which of the following is (are) true regarding clonazepam? (1) It is a benzodiazepine (2) It is effective as anxiolytic and musclerelaxing agent (3) It may be useful for phantom limb pain (4) It has short half-life
238. (A) Case report evidence suggests that clonazepam may have a useful effect in treatment of the shooting pain associated with phantom limb pain. Somnolence is a predominant side effect, and with this drug’s long half-life, daytime sedation may complicate use. As it belongs to the benzodiazepine group of drugs, anxiolysis and muscle relaxation may also be produced by its use, and this combination of properties may, in some patients, be useful.
99
239. Which of the following is true about lamotrigine? (1) It is an anticonvulsive agent (2) It is an NSAID (3) A rapid titration may result in skin rash (4) More than 300 mg/d is always needed for analgesia
239. (B) Case report evidence suggests that lamotrigine may reduce the symptoms of complex regional pain syndrome (type 1), with the sudomotor changes seen in this condition being alleviated along with pain and allodynia. Perhaps the major side effect limiting rapid titration to a therapeutic dose is skin rash. Higher doses may be used, but, if no effect is observed at 300 mg/d, further increases are unlikely to produce analgesia. In view of the relatively long half-life of lamotrigine, oncedaily dosing may be appropriate.
100
``` 240. The antidepressant(s) which is (are) tertiary amine(s) TCA: (1) Imipramine (2) Nortriptyline (3) Doxepin (4) Desipramine ```
``` 240. (B) The TCAs can be divided into tertiary amines and their demethylated secondary amine derivatives. Tertiary amine TCAs ("ACID T ") Amitriptyline Imipramine Tripramine Clomipramine Doxapin Secondary amine TCAs ("PAND") Nortriptyline Desipramine Protriptyline Amoxapine ```
101
241. Which of the following is true about the analgesic properties of TCAs? (1) The analgesic effects of TCA are independent of their effects on clinical depression (2) Onset of analgesia with TCA ranges from 3 to 7 days (3) Analgesia tends to occur at lower doses and plasma levels than that needed for antidepressant effects (4) TCA’s analgesic property is superior to that of SSRI’s
241. (E)
102
242. Which of the following is (are) true about TCAs? (1) They interact significantly with the opioid and benzodiazepine (2) They do not have potential for addiction (3) They block calcium channels (4) They can cause insomnia, restlessness and dry mouth
242. (C)
103
``` 243. Symptoms of TCA toxicity includes which of the following? (1) Hyperthermia (2) Tachycardia (3) Seizures (4) Hypertension ```
243. (A)
104
244. When prescribing antidepressants for pain (1) explain to the patient that you are primarily treating the pain not depression (2) explain to the patient that it will not work immediately (3) explain to the patient that it may help sleep (4) none of the above
244. (A)
105
245. Which of the following is (are) true regarding acetaminophen? (1) It is an aniline derivative (2) Induced analgesia is centrally mediated (3) It has peripheral mechanism of action (4) It is a drug of choice for relieving mild to moderate musculoskeletal pain
245. (E)
106
``` 246. Which of the following is (are) true regarding acetaminophen toxicity? (1) The liver gets the major insult (2) The heart gets the major insult (3) N-acetylcysteine is beneficial for treatment (4) Adrenergic agonists are beneficial for treatment ```
246. (B) The liver receives the major insult from acetaminophen toxicity, with the predominant lesion being acute centrilobular hepatic necrosis. It is suggested the use of the glutathione precursor of N-acetylcysteine for the treatment of acetaminophen intoxication in efforts to maintain hepatic reduced glutathione concentrations and adrenergic agonists may lower hepatic glutathione significantly.
107
``` 247. Which of the following is (are) true about baclofen? (1) It is good for muscle rigidity and spasticity (2) It is used for neuropathic pain (3) It is GABAB receptor agonist (4) It is GABAA receptor agonist ```
247. (A) Baclofen is the ρ-chlorophenyl derivative of GABA. Baclofen is a GABAB agonist that has been used for muscle spasms and spasticity, neuropathic pain, and so on. Baclofen may enhance the effectiveness of antiepileptic drugs in certain neuropathic pain states. Side effects include sedation, weakness, and confusion. Abrupt cessation may cause a withdrawal syndrome, such as hallucinations, anxiety, tachycardia, or seizures.
108
248. Which of the following is (are) true regarding botulinum toxin A? (1) The analgesic mechanism of action is well known (2) It can be administered intrathecally (3) Botox, Myobloc, and Dysport are available in the United States (4) Its effect lasts for about 3 to 6 months
248. (D) The two clinically available botulinum toxins in the United States are botulinum toxin type A and botulinum toxin type B. A different formulation of botulinum toxin Ais used in Europe as well as a version used in China but are currently not available in the United States. Effects seem to last for roughly 3 to 6 months after injection, at which point a repeat injection generally reproduces the effect. Although it is generally accepted that botulinum toxins may lead to diminished pain in patients with painful muscle spasms or cervical dystonia by diminishing muscle tone, it is also felt that botulinum toxin may itself possess analgesic properties. The mechanism of botulinum toxin–induced analgesia are unknown. The most evident mechanism of botulinum toxin-induced analgesia is via reduction of muscle spasm by cholinergic chemodenervation at motor end plates and by inhibition of gamma motor endings in muscle spindles. Future uses of botulinum toxins for analgesia may lead to redesign toxins for intrathecal use.
109
249. Which of the following is false regarding cyclobezaprine? (1) It is structurally similar to anticonvulsive agents (2) It has cholinergic side effects (3) It does not require dose adjustment for elderly patients (4) It can produce sinus tachycardia
249. (A) Cyclobenzaprine is structurally similar to TCAs and, as such, demonstrates significant anticholinergic side effects. It exhibits a sideeffect profile similar to that of the TCAs, including lethargy and agitation, although it usually does not appear to produce significant dysrhythmias beyond sinus tachycardia. Elderly patients seem to tolerate cyclobenzaprine less well and may develop hallucinations as well as significant anticholinergic side effects, such as sedation. The use of significant lower dosing schedules in elderly patients may be prudent.
110
``` 250. Which of the following is (are) false about lidocaine 5% topical patch? (1) Treatment for postherpetic neuralgia (2) It may not use more than 1 patch per day (3) It is used 12 hours ON and 12 hours OFF (4) High plasma levels are normally achieved through the skin ```
250. (C)
111
251. Steroids produce analgesia by (1) anti-inflammatory effects (2) suppressing ectopic discharge from injured nerves (3) reducing edema (4) blocking sodium channels
251. (A)